Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
In a clinical study of 313 patients, the recurrence rate for the Zhuling group (34.9%) was lower than the control group (64.7%) [PMID:11829890]. Another study of 146 patients showed a recurrence rate of 33.3% for Zhuling compared to 65.1% for the control group [PMID:7842985].
Oral administration of aqueous extract of sclerotia in normal rats significantly increased urine output starting at 4 hours [PMID:20083182].
A case report indicated that integrated therapy including Zhu-Ling-Tang helped decrease urinary total protein from 1367.9 mg/24h to 143.6 mg/24h over 143 days [PMID:30012398].
Polysaccharides isolated from mycelia significantly inhibited the growth of H22 implanted tumors in mice [PMID:23648036].
Sécurité et effets indésirables
Synthèse des preuves
Sources PubMed
- 1.PMID: 14987072 (2004) — Biologically active compounds from Aphyllophorales (polypore) fungi. · Journal of natural products
- 2.PMID: 24049465 (2005) — Morphological Characteristics of Hyphal Interaction between Grifola umbellata and its Companion Fungus. · Mycobiology
- 3.PMID: 3059066 (1988) — Traditional Chinese medicine and the search for new antineoplastic drugs. · Journal of ethnopharmacology
- 4.PMID: 37438987 (2023) — An integrated strategy by absorbed component characterization, pharmacokinetics, and activity evaluation for identification of potential nephroprotective substances in Zhu-Ling decoction. · Journal of separation science
- 5.PMID: 39048245 (2024)